Total Funding
29
50
Total FundingVenture - Series Unknown raised
Growth Score
-2 pts
Heat Score
-12 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
164031
Advancements in crosslinking technology for soft tissue repair
Eric Schaber: Vice PresidentPast Role: Tutogen Medical, Inc, International Sales Manager- Joseph Horn: President and CEO
About the Company
Colorado Therapeutics, LLC, (“Company”) a privately held company, is focused on developing xenogenic (sourced from different mammalian species) biologic tissue matrix products for a broad range of soft tissue reinforcement, regenerative, and vascular applications. The Company is leveraging over 15 years of innovative and proprietary tissue
processing technology to produce a superior biologic product that combines the benefits of currently available biologic and synthetic products.
